UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) Stock Competitors & Peer Comparison
See (UNH) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| UNH | $364.38 | +2.67% | 321.9B | 26.81 | $13.23 | +2.50% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.00% |
| CVS | $81.02 | +3.95% | 100.5B | 56.39 | $1.39 | +3.40% |
| ELV | $363.76 | +5.51% | 77.4B | 15.08 | $23.62 | +1.93% |
| CI | $287.51 | +4.29% | 74.5B | 12.74 | $22.19 | +2.16% |
| HUM | $228.51 | +6.17% | 26.9B | 22.73 | $9.84 | +1.58% |
| CNC | $47.97 | +14.72% | 21.4B | -3.22 | -$13.53 | N/A |
| MOH | $186.24 | +5.85% | 9.3B | 48.09 | $3.73 | N/A |
| OSCR | $17.88 | +6.34% | 4.5B | -10.17 | -$1.69 | N/A |
| ALHC | $21.38 | +1.16% | 4.3B | -190.41 | -$0.11 | N/A |
Stock Comparison
UNH vs ANTM Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, UNH is priced at $364.38, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas ANTM's P/E ratio is 18.99. In terms of profitability, UNH's ROE is +0.12%, compared to ANTM's ROE of +0.12%. Regarding short-term risk, UNH is less volatile compared to ANTM. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check ANTM's competition here
UNH vs CVS Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, CVS has a market cap of 100.5B. Regarding current trading prices, UNH is priced at $364.38, while CVS trades at $81.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas CVS's P/E ratio is 56.39. In terms of profitability, UNH's ROE is +0.12%, compared to CVS's ROE of +0.02%. Regarding short-term risk, UNH is less volatile compared to CVS. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check CVS's competition here
UNH vs ELV Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, ELV has a market cap of 77.4B. Regarding current trading prices, UNH is priced at $364.38, while ELV trades at $363.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas ELV's P/E ratio is 15.08. In terms of profitability, UNH's ROE is +0.12%, compared to ELV's ROE of +0.12%. Regarding short-term risk, UNH is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check ELV's competition here
UNH vs CI Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, CI has a market cap of 74.5B. Regarding current trading prices, UNH is priced at $364.38, while CI trades at $287.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas CI's P/E ratio is 12.74. In terms of profitability, UNH's ROE is +0.12%, compared to CI's ROE of +0.15%. Regarding short-term risk, UNH is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check CI's competition here
UNH vs HUM Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, HUM has a market cap of 26.9B. Regarding current trading prices, UNH is priced at $364.38, while HUM trades at $228.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas HUM's P/E ratio is 22.73. In terms of profitability, UNH's ROE is +0.12%, compared to HUM's ROE of +0.07%. Regarding short-term risk, UNH is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check HUM's competition here
UNH vs CNC Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, CNC has a market cap of 21.4B. Regarding current trading prices, UNH is priced at $364.38, while CNC trades at $47.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas CNC's P/E ratio is -3.22. In terms of profitability, UNH's ROE is +0.12%, compared to CNC's ROE of -0.28%. Regarding short-term risk, UNH is less volatile compared to CNC. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check CNC's competition here
UNH vs MOH Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, MOH has a market cap of 9.3B. Regarding current trading prices, UNH is priced at $364.38, while MOH trades at $186.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas MOH's P/E ratio is 48.09. In terms of profitability, UNH's ROE is +0.12%, compared to MOH's ROE of +0.04%. Regarding short-term risk, UNH is less volatile compared to MOH. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check MOH's competition here
UNH vs OSCR Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, OSCR has a market cap of 4.5B. Regarding current trading prices, UNH is priced at $364.38, while OSCR trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas OSCR's P/E ratio is -10.17. In terms of profitability, UNH's ROE is +0.12%, compared to OSCR's ROE of -0.39%. Regarding short-term risk, UNH is less volatile compared to OSCR. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check OSCR's competition here
UNH vs ALHC Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, ALHC has a market cap of 4.3B. Regarding current trading prices, UNH is priced at $364.38, while ALHC trades at $21.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas ALHC's P/E ratio is -190.41. In terms of profitability, UNH's ROE is +0.12%, compared to ALHC's ROE of -0.00%. Regarding short-term risk, UNH is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check ALHC's competition here
UNH vs CLOV Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, CLOV has a market cap of 1.3B. Regarding current trading prices, UNH is priced at $364.38, while CLOV trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas CLOV's P/E ratio is -14.79. In terms of profitability, UNH's ROE is +0.12%, compared to CLOV's ROE of -0.26%. Regarding short-term risk, UNH is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check CLOV's competition here
UNH vs BHG Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, UNH is priced at $364.38, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas BHG's P/E ratio is -0.12. In terms of profitability, UNH's ROE is +0.12%, compared to BHG's ROE of -0.70%. Regarding short-term risk, UNH is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check BHG's competition here
UNH vs CABR Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, CABR has a market cap of 17.5M. Regarding current trading prices, UNH is priced at $364.38, while CABR trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas CABR's P/E ratio is -2.59. In terms of profitability, UNH's ROE is +0.12%, compared to CABR's ROE of -3.00%. Regarding short-term risk, UNH is less volatile compared to CABR. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check CABR's competition here
UNH vs BMGL Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, BMGL has a market cap of 11.5M. Regarding current trading prices, UNH is priced at $364.38, while BMGL trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas BMGL's P/E ratio is -1.36. In terms of profitability, UNH's ROE is +0.12%, compared to BMGL's ROE of -1.95%. Regarding short-term risk, UNH is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check BMGL's competition here
UNH vs MRAI Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, MRAI has a market cap of 5.6M. Regarding current trading prices, UNH is priced at $364.38, while MRAI trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas MRAI's P/E ratio is -0.11. In terms of profitability, UNH's ROE is +0.12%, compared to MRAI's ROE of +0.52%. Regarding short-term risk, UNH is less volatile compared to MRAI. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check MRAI's competition here
UNH vs NIVF Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, NIVF has a market cap of 1.1M. Regarding current trading prices, UNH is priced at $364.38, while NIVF trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas NIVF's P/E ratio is 0.05. In terms of profitability, UNH's ROE is +0.12%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, UNH is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for UNH.Check NIVF's competition here
UNH vs AET Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, AET has a market cap of 0. Regarding current trading prices, UNH is priced at $364.38, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas AET's P/E ratio is N/A. In terms of profitability, UNH's ROE is +0.12%, compared to AET's ROE of +0.11%. Regarding short-term risk, UNH is more volatile compared to AET. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check AET's competition here
UNH vs GTS Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, GTS has a market cap of 0. Regarding current trading prices, UNH is priced at $364.38, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas GTS's P/E ratio is 10.41. In terms of profitability, UNH's ROE is +0.12%, compared to GTS's ROE of +0.07%. Regarding short-term risk, UNH is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check GTS's competition here
UNH vs MGLN Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, UNH is priced at $364.38, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas MGLN's P/E ratio is 8.49. In terms of profitability, UNH's ROE is +0.12%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, UNH is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check MGLN's competition here
UNH vs UAM Comparison April 2026
UNH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, UNH stands at 321.9B. In comparison, UAM has a market cap of 0. Regarding current trading prices, UNH is priced at $364.38, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
UNH currently has a P/E ratio of 26.81, whereas UAM's P/E ratio is N/A. In terms of profitability, UNH's ROE is +0.12%, compared to UAM's ROE of +0.17%. Regarding short-term risk, UNH is more volatile compared to UAM. This indicates potentially higher risk in terms of short-term price fluctuations for UNH.Check UAM's competition here